Results 31 to 40 of about 3,131 (178)

Value of MitraClip in Reducing Functional Mitral Regurgitation

US Cardiology Review, 2019
Patients with heart failure who have secondary severe mitral regurgitation due to left ventricular dysfunction have a poor prognosis, with high rates of rehospitalization and mortality.
Mehmet Ali Elbey, Luis Augusto Palma Dallan, Guilherme Ferragut Attizzani   +2 more
doaj   +1 more source

Impact of post-procedural length of stay on short-term outcomes and readmissions after TAVR and MitraClip

American Heart Journal Plus, 2022
Background: Post-procedural hospital length of stay (P-LOS) is an important determinant of cost-related outcomes. In the present study, we aimed to assess the impact of P-LOS on short-term outcomes after transcatheter aortic valve replacement (TAVR) and ...
Omar M. Abdelfattah, Abdelrahman I. Abushouk, Anas M. Saad, Mohamed M. Gad, Toshiaki Isogai, Yehia Saleh, Shashank Shekhar, Mina Iskander, Mohamed Omer, Ryan Kaple, Amar Krishnaswamy, Samir R. Kapadia   +11 more
doaj   +1 more source

Atrial Fibrillation Predicts Long-Term Outcome after Transcatheter Edge-to-Edge Mitral Valve Repair by MitraClip Implantation

Biomolecules, 2018
Background: Atrial fibrillation is common in patients with mitral regurgitation (MR) and has a negative impact on the clinical outcome of patients with valvular heart disease.
Mirjam Keßler, Alexander Pott, Elnura Mammadova, Julia Seeger, Jochen Wöhrle, Wolfgang Rottbauer, Sinisa Markovic   +6 more
doaj   +1 more source

Complications following transcatheter edge-to-edge mitral valve repair: Personal experience and review of the literature

Cardiology Journal, 2023
Mitral valve dysfunction affects around 2% of the population and its incidence is still increasing, making it the second most common valvular heart disease, after aortic stenosis.
Dominik Maj, Karolina Jasińska-Gniadzik, Tomasz Kopiec, Małgorzata Wieteska, Aleksandra Gąsecka, Adam Rdzanek, Adriaan O. Kraaijeveld, Krzysztof Pujdak, Marcin Grabowski, Arkadiusz Pietrasik   +9 more
doaj   +1 more source

Comparativa de la reparación valvular mitral y el dispositivo MitraClip® en el tratamiento de la insuficiencia mitral severa

Cirugía Cardiovascular, 2017
Introducción: La insuficiencia mitral sintomática tiene pronóstico desfavorable sin tratamiento quirúrgico. Esto lleva al desarrollo de técnicas menos invasivas para pacientes no candidatos a cirugía.
Isabel Pernía-Oreña, Francisco M. Sánchez-Silos, Pedro Alados-Arboledas, Daniela I. Hervas-Sotomayor, Javier Arias-Dachary, Azahara Fernández-Carbonell, Jose M. Turégano-Cisneros, Javier Moya-González, Carlos M. Merino-Cejas, Jaime Casares-Mediavilla, Maria T. Conejero-Jurado, Laura I. Inga-Tavara, Maria C. Muñoz-Villanueva, Ignacio Muñoz-Carvajal   +13 more
doaj   +1 more source

Sex-Specific Difference in Outcomes after Transcatheter Mitral Valve Repair with MitraClip Implantation: A Systematic Review and Meta-Analysis

Journal of Interventional Cardiology, 2022
Background. Implantation of the MitraClip is a safe and effective therapy for mitral valve repair in patients ineligible for surgery or at high risk of adverse surgical outcomes.
Fuqiang Sun, Honghao Liu, Qi Zhang, Jiawei Zhou, Haibo Zhan, Fanfan Lu   +5 more
doaj   +1 more source

Mitral and Tricuspid Transcatheter Interventions Current Indications and Future Directions

Frontiers in Cardiovascular Medicine, 2020
Valvular heart disease is responsible for a high rate of morbidity and mortality, especially in the elderly population. With the emergence of new transcatheter treatment options, the therapeutic spectrum for patients with valvular heart disease has ...
Mirjam Gauri Winkel, Fabien Praz, Peter Wenaweser, Peter Wenaweser   +3 more
doaj   +1 more source

Interventional therapies for chronic heart failure: An overview of recent developments

ESC Heart Failure, Volume 12, Issue 2, Page 1081-1094, April 2025.
Abstract Heart failure (HF), the final manifestation of most cardiovascular diseases, has become a major global health concern, affecting millions of individuals. Despite basic drug treatments, patients present with high morbidity and mortality rates. However, recent advancements in interventional therapy have shown promising results in improving the ...
Bingchen Guo, Si Shi, Yutong Guo, Jie Xiong, Bo Wang, Zengxiang Dong, Dianyu Gao, Yingfeng Tu   +7 more
wiley   +1 more source

Simultaneous endovascular "edge-to-edge" clipping of the mitral valve leaflets and closure of the left atrial appendage in a high surgical risk patient

Alʹmanah Kliničeskoj Mediciny, 2022
Mitral regurgitation is one of the most common valvular heart diseases, with the gold standard of its treatment being an open surgical intervention. However, it is not always performed in patients with a high surgical risk.
Sergey P. Semitko, Dzhamil A. Asadov, Anna N. Rogatova, Alexander V. Stepanov, Natalya S. Mesyats, Natalya L. Pak, Tamara S. Sandodze, Viktoria V. Fomenko, Imomali K. Kamolov, Andrey N. Pankov, Olga V. Zakharova, Alexey V. Azarov, Irina E. Chernysheva, David G. Ioseliani   +13 more
doaj   +1 more source

Prognostic role of TAPSE to PASP ratio in outpatients with left ventricular systolic dysfunction

ESC Heart Failure, Volume 12, Issue 2, Page 912-922, April 2025.
Abstract Aims Few data are available regarding the role of tricuspid annulus plane systolic excursion to pulmonary artery systolic pressure (TAPSE/PASP), a measurement of right ventricular to pulmonary artery coupling, in patients with chronic heart failure and left ventricular systolic dysfunction.
Mauro Riccardi, Matteo Pagnesi, Rossana Corso, Antonio M. Sammartino, Daniela Tomasoni, Riccardo M. Inciardi, Carlo M. Lombardi, Marianna Adamo, Savina Nodari, Marco Metra   +9 more
wiley   +1 more source